A Study Evaluating The Efficacy of Long-Term Bosentan Treatment In Reducing The Risk of Developing Pulmonary Arterial Hypertension (PAH) In Patients With Systemic Sclerosis
Latest Information Update: 28 Oct 2016
At a glance
- Drugs Bosentan (Primary)
- Indications Pulmonary arterial hypertension; Ulcer
- Focus Therapeutic Use
- 28 Oct 2016 New trial record